2023 Q1 Form 10-K Financial Statement

#000155837022005426 Filed on April 14, 2022

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1 2022
Revenue $209.5M $241.0M $991.6M
YoY Change -13.08% -4.34% 26.59%
Cost Of Revenue $126.7M $143.7M $584.1M
YoY Change -11.82% -0.44% 23.85%
Gross Profit $82.78M $97.32M $407.5M
YoY Change -14.94% -9.56% 30.74%
Gross Profit Margin 39.52% 40.38% 41.1%
Selling, General & Admin $70.58M $79.56M $307.6M
YoY Change -11.29% 0.37% 18.23%
% of Gross Profit 85.26% 81.76% 75.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.802M $5.175M $20.39M
YoY Change -7.21% 10.65% 5.89%
% of Gross Profit 5.8% 5.32% 5.0%
Operating Expenses $75.38M $84.74M $307.6M
YoY Change -11.04% 6.9% 18.23%
Operating Profit $7.400M $12.58M $79.52M
YoY Change -41.16% -46.93% 149.01%
Interest Expense $754.0K -$99.00K $306.0K
YoY Change -861.62% -60.57%
% of Operating Profit 10.19% -0.79% 0.38%
Other Income/Expense, Net
YoY Change
Pretax Income $8.154M $12.48M $79.24M
YoY Change -34.65% -47.26% 152.4%
Income Tax $1.517M $2.639M $17.00M
% Of Pretax Income 18.6% 21.15% 21.46%
Net Earnings $6.637M $9.839M $62.24M
YoY Change -32.54% -45.34% 159.57%
Net Earnings / Revenue 3.17% 4.08% 6.28%
Basic Earnings Per Share $6.98
Diluted Earnings Per Share $0.81 $1.155M $6.91
COMMON SHARES
Basic Shares Outstanding 8.912M
Diluted Shares Outstanding 9.013M

Balance Sheet

Concept 2023 Q1 2022 Q1 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $103.5M $49.79M $49.79M
YoY Change 107.87% -59.59% -59.59%
Cash & Equivalents $49.79M $49.79M $49.79M
Short-Term Investments
Other Short-Term Assets $13.59M $15.00M $15.00M
YoY Change -9.37% -13.81% -13.81%
Inventory $105.8M $123.8M $123.8M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $222.9M $192.6M $192.6M
YoY Change 15.72% -21.21% -21.19%
LONG-TERM ASSETS
Property, Plant & Equipment $317.3M $75.28M $277.1M
YoY Change 321.48% 18.53% 13.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.076M $1.317M $4.309M
YoY Change 209.49% 71.26% -38.44%
Total Long-Term Assets $321.4M $281.4M $281.4M
YoY Change 14.2% 12.5% 12.48%
TOTAL ASSETS
Total Short-Term Assets $222.9M $192.6M $192.6M
Total Long-Term Assets $321.4M $281.4M $281.4M
Total Assets $544.3M $474.0M $474.0M
YoY Change 14.82% -4.16% -4.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.67M $98.88M $98.88M
YoY Change -18.42% 16.56% 16.6%
Accrued Expenses $79.54M $14.53M $88.23M
YoY Change 447.34% -12.42% -5.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $160.6M $187.5M $187.5M
YoY Change -14.36% 2.53% 2.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $217.3M $2.104M $170.4M
YoY Change 10226.09% -7.96% 15.06%
Total Long-Term Liabilities $217.3M $2.104M $170.4M
YoY Change 10226.09% -7.96% 15.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $160.6M $187.5M $187.5M
Total Long-Term Liabilities $217.3M $2.104M $170.4M
Total Liabilities $377.8M $357.9M $357.9M
YoY Change 5.57% 8.13% 8.12%
SHAREHOLDERS EQUITY
Retained Earnings $331.1M $272.2M
YoY Change 21.64% 29.65%
Common Stock $102.6M $101.2M
YoY Change 1.39% 5.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $267.2M $257.2M
YoY Change 3.89% 81.23%
Treasury Stock Shares $7.473M
Shareholders Equity $166.4M $116.1M $116.1M
YoY Change
Total Liabilities & Shareholders Equity $544.3M $474.0M $474.0M
YoY Change 14.82% -4.16% -4.16%

Cashflow Statement

Concept 2023 Q1 2022 Q1 2022
OPERATING ACTIVITIES
Net Income $6.637M $9.839M $62.24M
YoY Change -32.54% -45.34% 159.57%
Depreciation, Depletion And Amortization $4.802M $5.175M $20.39M
YoY Change -7.21% 10.65% 5.89%
Cash From Operating Activities $28.81M $19.47M $74.32M
YoY Change 48.02% -59.36% -32.96%
INVESTING ACTIVITIES
Capital Expenditures $3.069M -$8.899M -$29.71M
YoY Change -134.49% 74.49% 74.75%
Acquisitions
YoY Change
Other Investing Activities $0.00 $35.46M $192.0K
YoY Change -100.0% 6992.4% -99.56%
Cash From Investing Activities -$3.069M $26.56M -$29.52M
YoY Change -111.55% -677.46% -210.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $115.3M
YoY Change 250.83%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K -8.264M -118.2M
YoY Change -99.76% -50.51% 244.58%
NET CHANGE
Cash From Operating Activities 28.81M 19.47M 74.32M
Cash From Investing Activities -3.069M 26.56M -29.52M
Cash From Financing Activities -20.00K -8.264M -118.2M
Net Change In Cash 25.72M 37.77M -73.39M
YoY Change -31.88% 41.97% -171.08%
FREE CASH FLOW
Cash From Operating Activities $28.81M $19.47M $74.32M
Capital Expenditures $3.069M -$8.899M -$29.71M
Free Cash Flow $25.74M $28.37M $104.0M
YoY Change -9.24% -46.48% -18.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-29
CY2021 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2022 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001318484
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Trading Symbol
TradingSymbol
CTRN
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-01-29
CY2022 dei Entity File Number
EntityFileNumber
000-51315
CY2022 dei Entity Registrant Name
EntityRegistrantName
CITI TRENDS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2150697
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
104 Coleman Boulevard
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Savannah
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
31408
CY2022 dei City Area Code
CityAreaCode
912
CY2022 dei Local Phone Number
LocalPhoneNumber
236-1561
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $.01 Par Value
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Public Float
EntityPublicFloat
682276483
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8670237
CY2022 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2022 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2021 dei Auditor Name
AuditorName
KPMG LLP
CY2021 dei Auditor Location
AuditorLocation
Jacksonville, Florida
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123177000
CY2022Q1 us-gaap Inventory Net
InventoryNet
123835000
CY2021Q1 us-gaap Inventory Net
InventoryNet
103845000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14997000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17420000
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3987000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
192607000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
244442000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75282000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63514000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
201827000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
179673000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2992000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6195000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1317000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
769000
CY2022Q1 us-gaap Assets
Assets
474025000
CY2021Q1 us-gaap Assets
Assets
494593000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
98879000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
84832000
CY2021Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
29315000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4623000
CY2022Q1 us-gaap Deferred Income
DeferredIncome
364000
CY2021Q1 us-gaap Deferred Income
DeferredIncome
500000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
187474000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
182845000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168304000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47803000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46983000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14532000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16592000
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
25896000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
145828000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2104000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2286000
CY2022Q1 us-gaap Liabilities
Liabilities
357882000
CY2021Q1 us-gaap Liabilities
Liabilities
330959000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16090365
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15981394
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8617210
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9876901
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
159000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
158000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
101037000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95484000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
272158000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
209918000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7473155
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6104493
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
257211000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
141926000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
116143000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
163634000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
474025000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
494593000
CY2022 us-gaap Revenues
Revenues
991595000
CY2021 us-gaap Revenues
Revenues
783294000
CY2020 us-gaap Revenues
Revenues
781925000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
584063000
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
471618000
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
484740000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
307622000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
260198000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
259629000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2233000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20393000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19259000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18535000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
286000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
472000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
79517000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
31933000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
18549000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1577000
CY2022 us-gaap Interest Expense
InterestExpense
306000
CY2021 us-gaap Interest Expense
InterestExpense
776000
CY2020 us-gaap Interest Expense
InterestExpense
158000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79242000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31395000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19968000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3465000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62240000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23978000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16503000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.98
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.33
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.91
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.41
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8912000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10283000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11674000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9013000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10325000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11699000
CY2022 us-gaap Profit Loss
ProfitLoss
62240000
CY2021 us-gaap Profit Loss
ProfitLoss
23978000
CY2020 us-gaap Profit Loss
ProfitLoss
16503000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20393000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19259000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18535000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50455000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
48242000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
45463000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
286000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
472000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-201000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-39000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3203000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
474000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-130000
CY2022 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
804000
CY2021 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
1042000
CY2020 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
1012000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4776000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2912000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2121000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20381000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33564000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1216000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2011000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7718000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1588000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
278000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
14000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12833000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5083000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5560000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53187000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-38346000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-45282000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
16302000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
267000
CY2022 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-8610000
CY2021 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
5809000
CY2020 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-1581000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-136000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
28000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74319000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110858000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42609000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
35272000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
43759000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
59836000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
35272000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
522000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
43840000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
29707000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16956000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
24175000
CY2022 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
192000
CY2021 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
416000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
832000
CY2020 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
573000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29515000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26697000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7606000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
43700000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
43700000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
270000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2638000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
608000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
733000
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
3765000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
115285000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
32861000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28445000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118193000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34301000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32943000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-73389000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103254000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2060000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123177000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19923000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17863000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123177000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19923000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
176000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
731000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
127000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22409000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1134000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4477000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2847000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1392000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4000000
CY2022 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3415000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
187425000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2121000
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
736000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
28445000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
3765000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16503000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
171044000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2912000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
116143000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
608000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
32861000
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
832000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23978000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
163634000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2022 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3415000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4776000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2638000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
115285000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62240000
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Helvetica';font-size:9.5pt;font-weight:bold;">1. Organization and Business</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0.05pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">Citi Trends, Inc. and its subsidiary (the “Company”) is a growing specialty value retailer of apparel, accessories and home trends for way less spend primarily for African American and Latinx families in the United States. As of January 29, 2022, the Company operated </span><span style="font-family:'Helvetica';font-size:9.5pt;">609</span><span style="font-family:'Helvetica';font-size:9.5pt;"> stores in urban, suburban and rural markets in </span><span style="font-family:'Helvetica';font-size:9.5pt;">33</span><span style="font-family:'Helvetica';font-size:9.5pt;"> states.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">Since early 2020, the global economy has been affected by COVID-19. The COVID-19 pandemic has caused, and may continue to cause, significant volatility and disruptions in the Company’s business</span><span style="font-family:'Helvetica';font-size:9.5pt;">, including the temporary closure of stores and limited store operating hours, reduced customer traffic and consumer spending, and delays in the manufacturing and shipping of products. Certain government actions to </span><span style="font-family:'Helvetica';font-size:9.5pt;">gradually ease restrictions, provide economic stimulus and distribute vaccines have resulted in signs of economic recovery. However, t</span><span style="font-family:'Helvetica';font-size:9.5pt;">he Company</span><span style="font-family:'Helvetica';font-size:9.5pt;"> cannot reasonably predict the extent to which our future business will be impacted by the pandemic. </span></p>
CY2022Q1 us-gaap Number Of Stores
NumberOfStores
609
CY2022Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
CY2022 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;font-style:italic;font-weight:bold;">Fiscal Year</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;min-height:1.15pt;margin:0pt 0pt 8pt 0.05pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The Company’s fiscal year ends on the Saturday closest to January 31 of each year. The years ended January 29, 2022, January 30, 2021 and February 1, 2020 are referred to as fiscal 2021, fiscal 2020 and fiscal 2019, respectively, in the accompanying consolidated financial statements. Fiscal 2021, 2020 and 2019 are all comprised of </span><span style="font-family:'Helvetica';font-size:9.5pt;">52</span><span style="font-family:'Helvetica';font-size:9.5pt;"> weeks. </span></p>
CY2020 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2021 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2022 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and apply judgments that affect the reported amounts. Actual results could differ from those estimates.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The most significant estimates include those used in the valuation of inventory, property and equipment, self-insurance liabilities, leases and income taxes. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively.</span></p>
CY2022Q1 ctrn Allowances For Inventory Shrinkage
AllowancesForInventoryShrinkage
4400000
CY2021Q1 ctrn Allowances For Inventory Shrinkage
AllowancesForInventoryShrinkage
5200000
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
300000
CY2020 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
500000
CY2022 ctrn Self Insured Maximum Retention Or Deductible Amount Each Claim Under Workers Compensation
SelfInsuredMaximumRetentionOrDeductibleAmountEachClaimUnderWorkersCompensation
250000
CY2022 ctrn Self Insured Maximum Retention Or Deductible Amount Each Claim Under Employee Medical
SelfInsuredMaximumRetentionOrDeductibleAmountEachClaimUnderEmployeeMedical
100000
CY2022 ctrn Period Customers Can Return Merchandise
PeriodCustomersCanReturnMerchandise
P30D
CY2022Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
200000
CY2021Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
300000
CY2021Q1 us-gaap Contract With Customer Right To Recover Product Current
ContractWithCustomerRightToRecoverProductCurrent
100000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10325239
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11699000
CY2022 ctrn Distribution Center Costs
DistributionCenterCosts
24900000
CY2021 ctrn Distribution Center Costs
DistributionCenterCosts
20300000
CY2020 ctrn Distribution Center Costs
DistributionCenterCosts
20800000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8911810
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10282718
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11673887
CY2022 ctrn Incremental Common Shares Attributable To Vesting Of Nonvested Restricted Stock
IncrementalCommonSharesAttributableToVestingOfNonvestedRestrictedStock
101122
CY2021 ctrn Incremental Common Shares Attributable To Vesting Of Nonvested Restricted Stock
IncrementalCommonSharesAttributableToVestingOfNonvestedRestrictedStock
42521
CY2020 ctrn Incremental Common Shares Attributable To Vesting Of Nonvested Restricted Stock
IncrementalCommonSharesAttributableToVestingOfNonvestedRestrictedStock
25113
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9012932
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1600000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1800000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1200000
CY2019Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2100000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
358727000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
342594000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
283445000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
279080000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75282000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63514000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11326000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5538000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2650000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2473000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1405000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
945000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13799000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6943000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3595000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2629000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
588000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-104000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
574000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-114000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-26000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3203000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
474000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-130000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3465000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
16641000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6593000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4193000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2936000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1777000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
791000
CY2022 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
152000
CY2021 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
168000
CY2020 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
308000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-158000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
99000
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
34000
CY2022 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
1433000
CY2021 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
878000
CY2020 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
1456000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1598000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
58000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
83000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-61000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
35000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
97000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3465000
CY2022Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1910000
CY2021Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1628000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
781000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
754000
CY2022Q1 ctrn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
55088000
CY2021Q1 ctrn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
49763000
CY2022Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3033000
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3033000
CY2021Q1 ctrn Deferred Tax Assets Fic Tax
DeferredTaxAssetsFICTax
416000
CY2021Q1 ctrn Deferred Tax Assets Legal Expense Reserve
DeferredTaxAssetsLegalExpenseReserve
128000
CY2021Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
532000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
778000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
646000
CY2022Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
620000
CY2022 ctrn Effective Income Tax Rate Reconciliation Nondeductible Compensation Expense Amount
EffectiveIncomeTaxRateReconciliationNondeductibleCompensationExpenseAmount
455000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1226000
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64443000
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
58498000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1556000
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1714000
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
62887000
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
56784000
CY2022Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
53342000
CY2021Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
47672000
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
5574000
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2040000
CY2022Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
979000
CY2021Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
877000
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
59895000
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
50589000
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2992000
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6195000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 ctrn Tax Credit Carryforward Valuation Allowance Number Of States
TaxCreditCarryforwardValuationAllowanceNumberOfStates
1
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1600000
CY2022 ctrn Tax Credit Carryback Period
TaxCreditCarrybackPeriod
P1Y
CY2022 ctrn Tax Credit Carryforward Period
TaxCreditCarryforwardPeriod
P20Y
CY2022 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1600000
CY2021 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1700000
CY2020 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1700000
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1369000
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1031000
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1404000
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
84.23
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
31.87
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
20.26
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
115285000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
32861000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
28445000
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
30000000.0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
678356
CY2022 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3400000
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
52737000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
50446000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
10938000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
8159000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1091000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1459000
CY2022 us-gaap Lease Cost
LeaseCost
64766000
CY2021 us-gaap Lease Cost
LeaseCost
60064000
CY2022 ctrn Rent Abatements Due To Number Of Leases Agreements Renegotiated
RentAbatementsDueToNumberOfLeasesAgreementsRenegotiated
700000
CY2021 ctrn Rent Abatements Due To Number Of Leases Agreements Renegotiated
RentAbatementsDueToNumberOfLeasesAgreementsRenegotiated
1000000.0
CY2022 ctrn Accrued Lease Liabilities Of Rent Abatement Agreements Renegotiated
AccruedLeaseLiabilitiesOfRentAbatementAgreementsRenegotiated
400000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
53317000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
50918000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
42114000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
31622000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
21246000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
34818000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
234035000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17928000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
216107000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
56932000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
47075000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
75359000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
60144000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M25D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M13D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0286
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0311

Files In Submission

Name View Source Status
0001558370-22-005426-index-headers.html Edgar Link pending
0001558370-22-005426-index.html Edgar Link pending
0001558370-22-005426.txt Edgar Link pending
0001558370-22-005426-xbrl.zip Edgar Link pending
ctrn-20220129.xsd Edgar Link pending
ctrn-20220129x10k.htm Edgar Link pending
ctrn-20220129x10k002.jpg Edgar Link pending
ctrn-20220129x10k_htm.xml Edgar Link completed
ctrn-20220129xex10d8.htm Edgar Link pending
ctrn-20220129xex10d8001.jpg Edgar Link pending
ctrn-20220129xex21d1.htm Edgar Link pending
ctrn-20220129xex23d1.htm Edgar Link pending
ctrn-20220129xex23d2.htm Edgar Link pending
ctrn-20220129xex31d1.htm Edgar Link pending
ctrn-20220129xex31d2.htm Edgar Link pending
ctrn-20220129xex32d1.htm Edgar Link pending
ctrn-20220129xex32d2.htm Edgar Link pending
ctrn-20220129_cal.xml Edgar Link unprocessable
ctrn-20220129_def.xml Edgar Link unprocessable
ctrn-20220129_lab.xml Edgar Link unprocessable
ctrn-20220129_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending